Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2014, Article ID 236905, 7 pages
http://dx.doi.org/10.1155/2014/236905
Review Article

Sarcoidosis: Sex-Dependent Variations in Presentation and Management

Department of Ophthalmology, Northwestern University Feinberg School of Medicine, 645 North Michigan Avenue, Suite 440, Chicago, IL 60611, USA

Received 3 October 2013; Accepted 19 May 2014; Published 2 June 2014

Academic Editor: Janet L. Davis

Copyright © 2014 Andrea D. Birnbaum and Lana M. Rifkin. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. C. Iannuzzi, B. A. Rybicki, and A. S. Teirstein, “Sarcoidosis,” The New England Journal of Medicine, vol. 357, no. 21, pp. 2153–2165, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. J. E. Gottlieb, H. L. Israel, R. M. Steiner, J. Triolo, and H. Patrick, “Outcome in sarcoidosis: the relationship of relapse to corticosteroid therapy,” Chest, vol. 111, no. 3, pp. 623–631, 1997. View at Google Scholar · View at Scopus
  3. “Statement on sarcoidosis. Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS board of directors and by the ERS executive committee,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 2, pp. 736–755, 1999.
  4. R. P. Baughman, D. B. Winget, E. H. Bowen, and E. E. Lower, “Predicting respiratory failure in sarcoidosis patients,” Sarcoidosis Vasculitis and Diffuse Lung Disease, vol. 14, no. 2, pp. 154–158, 1997. View at Google Scholar · View at Scopus
  5. M. A. Judson, “The diagnosis of sarcoidosis,” Clinics in Chest Medicine, vol. 29, no. 3, pp. 415–427, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Tomita, S. Sato, R. Matsuda et al., “Serum lysozyme levels and clinical features of sarcoidosis,” Lung, vol. 177, no. 3, pp. 161–167, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Nakamura, S. Ohara, K. Maruyama, Y.-I. Takei, M. Shindo, and N. Yanagisawa, “Systemic sarcoidosis: a case with a focal hydrocephalus and elevated lysozyme and angiotensin-converting enzyme in the cerebrospinal fluid,” Journal of Neurology, vol. 246, no. 4, pp. 320–322, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. O. P. Sharma, “Vitamin D, calcium, and sarcoidosis,” Chest, vol. 109, no. 2, pp. 535–539, 1996. View at Google Scholar · View at Scopus
  9. G. L. Barbour, J. W. Coburn, E. Slatopolsky, A. W. Norman, and R. L. Horst, “Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D,” The New England Journal of Medicine, vol. 305, no. 8, pp. 440–443, 1981. View at Google Scholar · View at Scopus
  10. J. Mambretti, “Chest x-ray stages of sarcoidosis,” Journal of Insurance Medicine, vol. 36, no. 1, pp. 91–92, 2004. View at Google Scholar · View at Scopus
  11. M. B. Gotway, M. L. Storto, J. A. Golden, G. P. Reddy, and W. R. Webb, “Incidental detection of thoracic sarcoidosis on whole-body 18Fluorine-2- Fluoro-2-Deoxy-D-Glucose positron emission tomography,” Journal of Thoracic Imaging, vol. 15, no. 3, pp. 201–204, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. G. W. Hunninghake, U. Costabel, M. Ando et al., “ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders,” Sarcoidosis, Vasculitis and Diffuse Lung Diseases, vol. 16, no. 2, pp. 149–173, 1999. View at Google Scholar
  13. S. Löfgren, “Primary pulmonary sarcoidosis. I. Early signs and symptoms,” Acta Medica Scandinavica, vol. 145, no. 6, pp. 424–431, 1953. View at Google Scholar
  14. J. Mañá, C. Gómez-Vaquero, A. Montero et al., “Lofgren's syndrome revisited: a study of 186 patients,” American Journal of Medicine, vol. 107, no. 3, pp. 240–245, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. M. A. Judson, B. W. Thompson, D. L. Rabin et al., “The diagnostic pathway to sarcoidosis,” Chest, vol. 123, no. 2, pp. 406–412, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. C. D. Obenauf, H. E. Shaw, C. F. Sydnor, and G. K. Klintworth, “Sarcoidosis and its ophthalmic manifestations,” American Journal of Ophthalmology, vol. 86, no. 5, pp. 648–655, 1978. View at Google Scholar · View at Scopus
  17. L. E. Siltzbach, D. G. James, E. Neville et al., “Course and prognosis of sarcoidosis around the world,” American Journal of Medicine, vol. 57, no. 6, pp. 847–852, 1974. View at Publisher · View at Google Scholar · View at Scopus
  18. D. G. James, R. Anderson, D. Langley, and D. Ainslie, “Ocular sarcoidosis,” The British Journal of Ophthalmology, vol. 48, pp. 461–470, 1964. View at Google Scholar · View at Scopus
  19. A. D. Birnbaum, F. S. Oh, A. Chakrabarti, H. H. Tessler, and D. A. Goldstein, “Clinical features and diagnostic evaluation of biopsy-proven ocular sarcoidosis,” Archives of Ophthalmology, vol. 129, no. 4, pp. 409–413, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Izumi, “Are corticosteroids harmful to sarcoidosis?” Sarcoidosis, vol. 11, supplement 1, pp. 119–122, 2012. View at Google Scholar
  21. J. A. Stigt, J. E. Boers, A. H. Oostdijk, J.-W. K. van den Berg, and H. J. M. Groen, “Mediastinal incidentalomas,” Journal of Thoracic Oncology, vol. 6, no. 8, pp. 1345–1349, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. B. A. Rybicki, M. Major, J. Popovich Jr., M. J. Maliarik, and M. C. Iannuzzi, “Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization,” American Journal of Epidemiology, vol. 145, no. 3, pp. 234–241, 1997. View at Google Scholar · View at Scopus
  23. K.-E. Byg, N. Milman, and S. Hansen, “Sarcoidosis in Denmark 1980–1994. A registry-based incidence study comprising 5536 patients,” Sarcoidosis Vasculitis and Diffuse Lung Diseases, vol. 20, no. 1, pp. 46–52, 2003. View at Google Scholar · View at Scopus
  24. K. O. Forsén, N. Milman, A. Pietinalho, and O. Selroos, “Sarcoidosis in the Nordic countries 1950–1987,” Sarcoidosis, vol. 9, no. 2, pp. 140–141, 1992. View at Google Scholar · View at Scopus
  25. R. P. Baughman, A. S. Teirstein, M. A. Judson et al., “Clinical characteristics of patients in a case control study of sarcoidosis,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 10, pp. 1885–1889, 2001. View at Google Scholar · View at Scopus
  26. M. A. Judson, A. D. Boan, and D. T. Lackland, “The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States,” Sarcoidosis Vasculitis and Diffuse Lung Diseases, vol. 29, no. 2, pp. 119–127, 2012. View at Google Scholar · View at Scopus
  27. M. Yamaguchi, Y. Hosoda, R. Sasaki, and K. Aoki, “Epidemiological study on sarcoidosis in Japan. Recent trends in incidence and prevalence rates and changes in epidemiological features,” Sarcoidosis, vol. 6, no. 2, pp. 138–146, 1989. View at Google Scholar · View at Scopus
  28. C. E. Henke, G. Henke, L. R. Elveback, C. M. Beard, D. J. Ballard, and L. T. Kurland, “The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival,” American Journal of Epidemiology, vol. 123, no. 5, pp. 840–845, 1986. View at Google Scholar · View at Scopus
  29. N. Milman and O. Selroos, “Pulmonary sarcoidosis in the Nordic countries 1950–1982. Epidemiology and clinical picture,” Sarcoidosis, vol. 7, no. 1, pp. 50–57, 1990. View at Google Scholar · View at Scopus
  30. Y. C. Cozier, J. S. Berman, J. R. Palmer, D. A. Boggs, L. A. Wise, and L. Rosenberg, “Reproductive and hormonal factors in relation to incidence of sarcoidosis in US black women,” American Journal of Epidemiology, vol. 176, no. 7, pp. 635–641, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. K. T. Jørgensen, B. V. Pedersen, N. M. Nielsen, S. Jacobsen, and M. Frisch, “Childbirths and risk of female predominant and other autoimmune diseases in a population-based Danish cohort,” Journal of Autoimmunity, vol. 38, no. 2-3, pp. J81–J87, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Hillerdal, E. Nou, K. Osterman, and B. Schmekel, “Sarcoidosis: epidemiology and prognosis: a 15-year European study,” American Review of Respiratory Disease, vol. 130, no. 1, pp. 29–32, 1984. View at Google Scholar · View at Scopus
  33. P. Chevalet, R. Clément, O. Rodat, A. Moreau, J.-M. Brisseau, and J.-P. Clarke, “Sarcoidosis diagnosed in elderly subjects: retrospective study of 30 cases,” Chest, vol. 126, no. 5, pp. 1423–1430, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Varron, V. Cottin, A.-M. Schott, C. Broussolle, and P. Sève, “Late-onset sarcoidosis: a comparative study,” Medicine, vol. 91, no. 3, pp. 137–143, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. R. G. J. Marcellis, A. F. Lenssen, M. D. P. Elfferich et al., “Exercise capacity, muscle strength and fatigue in sarcoidosis,” European Respiratory Journal, vol. 38, no. 3, pp. 628–634, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Hinz, M. Fleischer, E. Brähler, H. Wirtz, and A. Bosse-Henck, “Fatigue in patients with sarcoidosis, compared with the general population,” General Hospital Psychiatry, vol. 33, no. 5, pp. 462–468, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Hinz, E. Brähler, R. Möde, H. Wirtz, and A. Bosse-Henck, “Anxiety and depression in sarcoidosis: the influence of age, gender, affected organs, concomitant diseases and dyspnea,” Sarcoidosis Vasculitis and Diffuse Lung Diseases, vol. 29, no. 2, pp. 139–146, 2012. View at Google Scholar · View at Scopus
  38. H. Yanardaǧ, Ö. Nuri Pamuk, and T. Karayel, “Cutaneous involvement in sarcoidosis: analysis of the features in 170 patients,” Respiratory Medicine, vol. 97, no. 8, pp. 978–982, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Grunewald and A. Eklund, “Sex-specific manifestations of Löfgren's syndrome,” American Journal of Respiratory and Critical Care Medicine, vol. 175, no. 1, pp. 40–44, 2007. View at Google Scholar
  40. A. Khaled, A. Souissi, F. Zeglaoui et al., “Cutaneous sarcoidosis in Tunisia,” Giornale Italiano di Dermatologia e Venereologia, vol. 143, no. 3, pp. 181–185, 2008. View at Google Scholar · View at Scopus
  41. J. Mañá, C. Gómez-Vaquero, A. Montero et al., “Lofgren's syndrome revisited: a study of 186 patients,” American Journal of Medicine, vol. 107, no. 3, pp. 240–245, 1999. View at Publisher · View at Google Scholar · View at Scopus
  42. N. Porter, H. L. Beynon, and H. S. Randeva, “Endocrine and reproductive manifestations of sarcoidosis,” QJM: Monthly Journal of the Association of Physicians, vol. 96, no. 8, pp. 553–561, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Antonelli, P. Fazzi, P. Fallahi, S. M. Ferrari, and E. Ferrannini, “Prevalence of hypothyroidism and Graves disease in sarcoidosis,” Chest, vol. 130, no. 2, pp. 526–532, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. C. O. Turk, M. Schacht, and L. Ross, “Diagnosis and management of testicular sarcoidosis,” Journal of Urology, vol. 135, no. 2, pp. 380–381, 1986. View at Google Scholar · View at Scopus
  45. A. Chalvardjian, “Sarcoidosis of the female genital tract,” American Journal of Obstetrics and Gynecology, vol. 132, no. 1, pp. 78–80, 1978. View at Google Scholar · View at Scopus
  46. M. Soheilian, K. Heidari, S. Yazdani, M. Shahsavari, H. Ahmadieh, and M. H. Dehghan, “Patterns of uveitis in a tertiary eye care center in Iran,” Ocular Immunology and Inflammation, vol. 12, no. 4, pp. 297–310, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Kitamei, N. Kitaichi, K. Namba et al., “Clinical features of intraocular inflammation in Hokkaido, Japan,” Acta Ophthalmologica, vol. 87, no. 4, pp. 424–428, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. Y.-M. Chung, Y.-C. Lin, Y.-T. Liu, S.-C. Chang, H.-N. Liu, and W.-H. Hsu, “Uveitis with biopsy-proven sarcoidosis in Chinese—a study of 60 patients in a uveitis clinic over a period of 20 years,” Journal of the Chinese Medical Association, vol. 70, no. 11, pp. 492–496, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. K. Ohara, A. Okubo, H. Sasaki, and K. Kamara, “Intraocular manifestations of systemic sarcoidosis,” Japanese Journal of Ophthalmology, vol. 36, no. 4, pp. 452–457, 1992. View at Google Scholar · View at Scopus
  50. A. Lobo, K. Barton, D. Minassian, R. M. du Bois, and S. Lightman, “Visual loss in sarcoid-related uveitis,” Clinical and Experimental Ophthalmology, vol. 31, no. 4, pp. 310–316, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Rothova, C. Alberts, E. Glasius, A. Kijlstra, H. J. Buitenhuis, and A. C. Breebaart, “Risk factors for ocular sarcoidosis,” Documenta Ophthalmologica, vol. 72, no. 3-4, pp. 287–296, 1989. View at Google Scholar · View at Scopus
  52. D. Khalatbari, S. Stinnett, R. M. McCallum, and G. J. Jaffe, “Demographic-related variations in posterior segment ocular sarcoidosis,” Ophthalmology, vol. 111, no. 2, pp. 357–362, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. A. D. Birnbaum, W. Huang, O. Sahin, H. H. Tessler, and D. A. Goldstein, “Ocular sarcoidosis misdiagnosed as primary intraocular lymphoma,” Retina, vol. 30, no. 2, pp. 310–316, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. K. Pathanapitoon, J. H. M. Goossens, T. C. van Tilborg, P. Kunavisarut, J. Choovuthayakorn, and A. Rothova, “Ocular sarcoidosis in Thailand,” Eye, vol. 24, no. 11, pp. 1669–1674, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. P. K. Kaiser, C. Y. Lowder, P. Sullivan et al., “Chest computerized tomography in the evaluation of uveitis in elderly women,” American Journal of Ophthalmology, vol. 133, no. 4, pp. 499–505, 2002. View at Publisher · View at Google Scholar · View at Scopus
  56. J. P. Cremers, M. Drent, A. Bast et al., “Multinational evidence-based World Association of Sarcoidosis and Other Granulomatous Disorders recommendations for the use of methotrexate in sarcoidosis: integrating systematic literature research and expert opinion of sarcoidologists worldwide,” Current Opinion in Pulmonary Medicine, vol. 19, no. 5, pp. 545–561, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. R. M. Tarantola, J. C. Folk, H. C. Boldt, and V. B. Mahajan, “Intravitreal bevacizumab during pregnancy,” Retina, vol. 30, no. 9, pp. 1405–1411, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. D. F. Cella, “Quality of life: concepts and definition,” Journal of Pain and Symptom Management, vol. 9, no. 3, pp. 186–192, 1994. View at Publisher · View at Google Scholar · View at Scopus
  59. D. E. Victorson, D. Cella, H. Grund, and M. A. Judson, “A conceptual model of health-related quality of life in sarcoidosis,” Quality of Life Research, vol. 23, no. 1, pp. 89–101, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. C. E. Cox, J. F. Donohue, C. D. Brown, Y. P. Kataria, and M. A. Judson, “Health-related quality of life of persons with sarcoidosis,” Chest, vol. 125, no. 3, pp. 997–1004, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. L. N. Saligan, G. Levy-Clarke, T. Wu et al., “Quality of life in sarcoidosis: comparing the impact of ocular and non-ocular involvement of the disease,” Ophthalmic Epidemiology, vol. 17, no. 4, pp. 217–224, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. C. E. Cox, J. F. Donohue, C. D. Brown, Y. P. Kataria, and M. A. Judson, “The sarcoidosis health questionnaire: a new measure of health-related quality of life,” American Journal of Respiratory and Critical Care Medicine, vol. 168, no. 3, pp. 323–329, 2003. View at Publisher · View at Google Scholar · View at Scopus
  63. J. M. Bourbonnais and L. Samavati, “Effect of gender on health related quality of life in sarcoidosis,” Sarcoidosis Vasculitis and Diffuse Lung Diseases, vol. 27, no. 2, pp. 96–102, 2010. View at Google Scholar · View at Scopus
  64. W. Krell, J. M. Bourbonnais, R. Kapoor, and L. Samavati, “Effect of smoking and gender on pulmonary function and clinical features in sarcoidosis,” Lung, vol. 190, no. 5, pp. 529–536, 2012. View at Publisher · View at Google Scholar · View at Scopus
  65. J. J. Swigris, A. L. Olson, T. J. Huie et al., “Sarcoidosis-related mortality in the United States from 1988 to 2007,” American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 11, pp. 1524–1530, 2011. View at Publisher · View at Google Scholar · View at Scopus
  66. S. J. Walsh and L. M. Rau, “Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States,” American Journal of Public Health, vol. 90, no. 9, pp. 1463–1466, 2000. View at Google Scholar · View at Scopus
  67. K. M. Pollard, “Gender differences in autoimmunity associated with exposure to environmental factors,” Journal of Autoimmunity, vol. 38, no. 2-3, pp. J177–J186, 2012. View at Publisher · View at Google Scholar · View at Scopus
  68. E. Tiniakou, K. H. Costenbader, and M. A. Kriegel, “Sex-specific environmental influences on the development of autoimmune diseases,” Clinical Immunology, vol. 149, no. 2, pp. 182–191, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. S. Sankaran-Walters, M. Macal, I. Grishina et al., “Sex differences matter in the gut: effect on mucosal immune activation and inflammation,” Biology of Sex Differences, vol. 4, no. 1, article 10, 2013. View at Google Scholar
  70. H. T. Jordan, S. D. Stellman, D. Prezant, A. Teirstein, S. S. Osahan, and J. E. Cone, “Sarcoidosis diagnosed after september 11, 2001, among adults exposed to the world trade center disaster,” Journal of Occupational and Environmental Medicine, vol. 53, no. 9, pp. 966–974, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. C. H. da Costa, V. L. Silva, G. M. Fabricio-Silva, M. Usnayo, R. Rufino, and L. C. Porto, “HLA in a cohort of Brazilian patients with sarcoidosis,” Human Immunology, vol. 74, no. 10, pp. 1326–1332, 2013. View at Publisher · View at Google Scholar · View at Scopus
  72. M. P. Mallampalli, E. Davies, D. Wood, H. Robertson, F. Polato, and C. L. Carter, “Role of environment and sex differences in the development of autoimmune diseases: a roundtable meeting report,” Journal of Women's Health, vol. 22, no. 7, pp. 578–586, 2013. View at Publisher · View at Google Scholar · View at Scopus